Intake of Alternate Day Iron tablets in Anaemia
Phase 2
Completed
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2019/01/017169
- Lead Sponsor
- Dr Elamparithi Pasupathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1.Adult males and females, with reduced Hemoglobin levels(less than or equal to 10g/dl) with Microcytic hypochromic anaemia in Peripheral blood smear AND/OR Serum ferritin levels below less than 50 mcg/L
Exclusion Criteria
1.Renal Failure
2.Chronic Liver disease
3.Cardiac failure
4.Pregnancy
5.Concomitant malignancy
6.Hemolytic anaemia
7.Chronic Inflammatory Diseases
8.Severe Anemia requiring a blood transfusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean difference in Hemoglobin between two groups at day 60.Timepoint: Mean difference in Hemoglobin between two groups at day 60.
- Secondary Outcome Measures
Name Time Method -Mean difference in Hemoglobin at day 30. <br/ ><br>-Mean difference in Reticulocyte count between 7th- 14th days. <br/ ><br>-Mean difference in Ferritin at day 60 <br/ ><br>Timepoint: -Mean difference in Hemoglobin at day 30. <br/ ><br>-Mean difference in Reticulocyte count between 7th- 14th days. <br/ ><br>-Mean difference in Ferritin at day 60 <br/ ><br>